Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salem Oaks is a private U.S. healthcare education and consulting company focused on pharmaceutical research and development literacy, patient engagement, and patient-advocacy capacity building. The company develops self-paced online courses, workshops, and consulting offerings that help patient organizations, patients, care partners, and industry stakeholders participate more effectively in drug discovery, clinical development, and regulatory engagement. Its flagship offering, The Biopharmaceutical Atlas of Discovery and Development, is an educational platform designed to explain the end-to-end medicine development process. Salem Oaks appears to operate as a services and education business rather than a drug developer, with an emphasis on rare disease and broader patient-community collaboration. The company also produces related content and community programming, including podcasts and storytelling or protocol-education initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salem Oaks.